The Latest Breaking News from Cardiology

Studies show that women with heart disease are more likely to be misdiagnosed than men, and will have worse outcomes for surgery. What is behind this bias and how can how it be fixed?

Heather Jacobs has heart failure and angina and was told in December that she'd be seen at a specialist cardiology clinic within three months. She's still waiting.

Annual conference of Interventional Cardiology Council begins

The U.S. Food and Drug Administration (FDA) has approved Incyte’s (NASDAQ:INCY) Pemazyre (pemigatinib), a selective fibroblast growth factor receptor (FGFR) inhibitor, for the treatment of adults with relapsed or refractory myeloid/lymphoid neoplasms (MLNs) with FGFR1 rearrangement. Incyte shares traded in a range of $71.38 to $72.98 on day volume of 1.25…